Pharmacokinetics and pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac

References 

1. Walters T, Raizman M, Ernest P, Gayton J, Lehmann R. In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac. J Cataract Refract Surg. 2007;33:1539–1545
   • Abstract
   • Full Text
   • Full-Text PDF (284 KB)
   • CrossRef
2. Bucci FA, Waterbury LD, Amico LM. Prostaglandin E₂ inhibition and aqueous concentration of ketorolac 0.4% (Acular LS) and nepafenac 0.1% (Nevanac) in patients undergoing phacoemulsification. Am J Ophthalmol. 2007;144:146–147
   • Abstract
   • Full Text
   • Full-Text PDF (157 KB)
   • CrossRef
3. Donnenfeld ED, Perry HD, Wittpenn JR, Solomon R, Nattis A, Chou T. Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve. J Cataract Refract Surg. 2006;32:1474–1482
   • Abstract
   • Full Text
   • Full-Text PDF (258 KB)
   • CrossRef